As Drug Makers Downplay Negotiated Prices, Advocates Use Grassroots Campaign To Press CEOs On Lawsuits

By Maaisha Osman / August 1, 2024 at 5:10 PM

As leading drugmakers hint to shareholders that Medicare's final price offers may not impact long-term sales, several prominent drug price control advocacy groups are gathering tens of thousands of signatures for a petition demanding drug makers withdraw their lawsuits against Medicare drug price negotiations.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.